West Pharmaceutical Services SG&A Expense (Quarterly) Insights

West Pharmaceutical Services Inc (WST)

377.33 -0.03 (-0.01%) USD | NYSE | Apr 18, 16:00

377.07 -0.26 (-0.07%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1990. Upgrade now.

Date	Value
December 31, 2023	90.00M
September 30, 2023	89.00M
June 30, 2023	88.40M
March 31, 2023	86.00M
December 31, 2022	85.70M
September 30, 2022	66.30M
June 30, 2022	81.50M
March 31, 2022	83.40M
December 31, 2021	98.00M
September 30, 2021	91.90M
June 30, 2021	92.70M
March 31, 2021	80.20M
December 31, 2020	76.30M
September 30, 2020	76.20M
June 30, 2020	77.70M
March 31, 2020	71.80M
December 31, 2019	69.00M
September 30, 2019	64.80M
June 30, 2019	70.30M
March 31, 2019	68.60M
December 31, 2018	59.70M
September 30, 2018	64.90M
June 30, 2018	70.00M
March 31, 2018	68.30M
December 31, 2017	59.60M

Date	Value
September 30, 2017	62.60M
June 30, 2017	61.30M
March 31, 2017	62.50M
December 31, 2016	60.70M
September 30, 2016	58.30M
June 30, 2016	62.50M
March 31, 2016	58.10M
December 31, 2015	62.40M
September 30, 2015	54.60M
June 30, 2015	71.70M
March 31, 2015	55.20M
December 31, 2014	58.80M
September 30, 2014	56.00M
June 30, 2014	57.50M
March 31, 2014	56.40M
December 31, 2013	60.00M
September 30, 2013	56.10M
June 30, 2013	59.70M
March 31, 2013	59.10M
December 31, 2012	58.60M
September 30, 2012	53.70M
June 30, 2012	54.40M
March 31, 2012	51.30M
December 31, 2011	48.40M
September 30, 2011	45.70M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

64.80M

Minimum

Sep 2019

98.00M

Maximum

Dec 2021

81.01M

Average

81.50M

Median

Jun 2022

SG&A Expense (Quarterly) Benchmarks